Page 4 of 6
p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2
E. W. Cloer, P. F. Siesser, E. M. Cousins, D. Goldfarb, D. D. Mowrey, J. S. Harrison, S. J. Weir, N. V. Dokholyan, M. B. Majora
08.20.2018
PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels
Lingxin Wang, Shannon G Zellmer, David M Printzenhoff and Neil A Castle
03.17.2018
A comprehensive Approach to Identifying Repurposed Drugs to Treat SCN8A Epilepsy
Talia A. Atkin, Chani M. Maher, Aaron C. Gerlach, Bryant C. Gay, Brett M. Antonio, Sonia C. Santos, Karen M. Padilla, JulieAnn Rader, Douglas S. Krafte, Matthew A. Fox, Gregory R. Stewart, Slavé Petrovski, Orrin Devinsky, Matthew Might, Steven Petrou, David B. Goldstein
02.05.2018
Discovery and in Vitro Optimization of 3‐Sulfamoylbenzamides as ROMK Inhibitors
Matthew F. Sammons, Sujay V. Kharade, Kevin J. Filipski, Markus Boehm, Aaron C. Smith, Andre Shavnya, Dilinie P. Fernando, Matthew S. Dowling, Philip A. Carpino, Neil A. Castle, Shannon G. Zellmer, Brett M. Antonio, James R. Gosset, Anthony Carlo, and Jerod S. Denton
01.19.2018
Page 4 of 6